20% of patients with cholangiocarcinoma or cancer of the bile ducts do not receive any treatment, mainly due to the rapid deterioration of the disease. It is a rare cancer, since it affects approximately 2% of cancer patients in Spain and 80% is diagnosed in advanced stages, with no operation possible. On the occasion of World Colangiocarcinoma Day, which coincides with Thursday, 19 February, the Tumors Association of Biliare Ways (ATUVIBI) aims…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
20% of patients with cholangiocarcinoma or cancer of the bile ducts do not receive any treatment, mainly due to the rapid deterioration of the disease. It is a rare cancer, since it affects approximately 2% of cancer patients in Spain and 80% is diagnosed in advanced stages, with no operation possible. On the occasion of World Colangiocarcinoma Day, which coincides with Thursday, 19 February, the Tumors Association of Biliare Ways (ATUVIBI) aims…